Differences

This shows you the differences between two versions of the page.

--- home:patients:cohort_statistics [02.07.2019] – [Recovery rate] sallieq
+++ home:patients:cohort_statistics [03.24.2019] – [Later information 2013] sallieq
@@ Line 14: / Line 14: @@
 The best data collected thus far (//as at 2010//) is from a 2008 survey of MP patients with autoimmune diseases, the methodology of which is [[home:publications:mp2008_survey|described here]]. That data was presented by Capt. Tom Perez, MPH, at the [[home:publications:perez_congress_on_autoimmunity_2008|2008 International Congress on Autoimmunity]].
-ARF is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP.
-==== Later information ====
+==== Later information 2013 ====
 //from DJ in California//
@@ Line 84: / Line 83: @@
 All Other Th1 disease success 59.8%
-What we who are a part of this forum, who stuck with the protocol long enough, who endured the IP and were able to keep a doctor, report is that this has a better than 50% success rate.
+</blockquote>
+<blockquote>What we who are a part of this forum, who stuck with the protocol long enough, who endured the IP and were able to keep a doctor, report is that this has a better than 50% success rate.
 Not just a 10% or the 20% I hoped for, but you/we report an overall 66% success rate.
-Now if this information can just be broad cast to the Conventional Medical world, maybe just maybe Dr. Marshall will be a hero not only to us but to thousands(perhaps millions) more out there suffering from Th1 diseases.
+Now if this information can just be broad cast to the Conventional Medical world, maybe just maybe Dr. Marshall will be a hero not only to us but to thousands(perhaps millions) more out there suffering from Th1 diseases.</blockquote>
-</blockquote>

home/patients/cohort_statistics.txt · Last modified: 09.14.2022 by 127.0.0.1